MyCite Mobile is a high-risk, highly regulated digital healthcare product designed to help patients with Major Depressive Disorder and Bipolar Disorder I build sustainable medication and adherence habits. It is especially helpful when patients experience low energy, low motivation, and emotional vulnerability.
This is not a “nice-looking app” project. It’s a behavior-change system developed under strict FDA digital health regulations, Human Factors and usability engineering standards, and strict documentation requirements.
After the redesign, onboarding completion increased from under 50% to 90%, and 90 day retention improved from nearly zero to 30%.
PROBLEM STATEMENT
Patients with mental health conditions, such as MDD and BP1, often disengaged during onboarding due to high cognitive and emotional demands at a time when their capacity was lowest. This resulted in low activation, unstable routines, and poor retention.
DESIGN CHALLENGE
"How might we redesign onboarding and early engagement to feel supportive and non-judgmental, reduce effort while respecting users’ autonomy and emotional state, support easy re-entry after lapses, and still meet Human Factors and FDA requirements for clarity, understanding, and safe use?"
DESIGN SOLUTION
We aim to create a design that feels non-judgmental, low-pressure, and emotionally safe, while also meeting Human Factors and FDA requirements.